B2B segment is expected to grow at the highest CAGR during the forecast period

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market. There is growing awareness among providers, payers, and employers about the benefits provided by digital therapeutics and the healthcare cost reductions achieved by their use.

Expected Revenue Growth:

[166 Pages Report] Theglobal digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025).

Major Growth Boosters:

The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.

Key Questions Addressed in The Report:

• Where will these developments take the industry in the mid to long-term?
• What types of annual and multi-year partnerships are companies in the digital therapeutics market exploring?
• Who are the key players in the market, and how intense is the competition?
• What are the recent contracts and agreements that key players have signed?
• What are the recent trends affecting digital therapeutics market players?

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724  

What This Report Will Provide?

The study involved four major activities in estimating the current size of the global digital therapeutics market. Exhaustive secondary research was conducted to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size.

The treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019.

The global digital therapeutics market is segmented into North America, Europe, the Asia Pacific, and the RoW. In 2019, North America (US and Canada) held the largest share of the market, followed by Europe. The major factors supporting market growth include the increasing investments in digital therapeutics, the influx of new start-ups, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements.

Request Sample Report:     https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724 

Regional Growth Analysis:

The global healthcare consulting services market was dominated by North America, followed by Europe in 2017. Factors such as increasing M&A activity, pricing pressure on pharmaceutical companies are driving the growth of the healthcare consulting services market in this region. Asia Pacific, however, is estimated to register the highest CAGR during the forecast period due to the increasing need for remote care and telemedicine in rural areas in the region.

Key Questions Addressed by the Report

• Where will these developments take the industry in the mid to long-term?
• What types of annual and multi-year partnerships are companies in the digital therapeutics market exploring?
• Who are the key players in the market, and how intense is the competition?
• What are the recent contracts and agreements that key players have signed?
• What are the recent trends affecting digital therapeutics market players?